一段式与两段式种植体支持固定和可摘修复体的随机对照临床试验:4至6年观察
经过4至6年随访,两种种植体均显示出较高的种植体与修复体生存率,除边缘骨水平变化外,生物学和技术结局无显著差异。
要点
- 一段式与两段式种植体在4至6年随访中均表现出较高的种植体生存率。
- 两段式种植体的边缘骨水平变化较一段式更明显(P < 0.001)。
- 两组在生物学并发症、技术并发症及修复体生存率上无显著差异。
核心结论
- 两种种植体系统在种植体和修复体水平均显示出高生存率。
- 除边缘骨水平变化外,两种种植体系统的生物学和技术结局无显著差异。
研究设计与样本
- 以最终修复体戴入为基线,进行1年及4至6年随访测量。
主要发现
- 随访4至6年时,种植体水平累积生存率为97.9%(S1:96.6%;S2:98.9%)。
- 患者水平种植体累积生存率为94.6%(S1:92.3%;S2:96.7%)。
- S1组边缘骨水平中位数从基线0.51 mm变为随访时0.49 mm,S2组从1.02 mm变为1.35 mm(P < 0.001)。
- 患者水平种植体周围黏膜炎发生率S1为7.7%、S2为10.0%,种植体周围炎发生率S1为7.7%、S2为13.3%。
- 患者水平总体生物学并发症发生率S1为15.4%、S2为23.3%(P = 0.517),总体技术并发症发生率S1为30.8%、S2为13.3%(P = 0.349),修复体生存率S1为93.1%、S2为100%(P > 0.05)。
临床怎么用
- 一段式和两段式种植体均可作为固定或可摘修复体的支持方案,两者均具有高生存率。
- 临床选择时需考虑两段式种植体可能伴随更明显的边缘骨水平变化。
- 应关注两组患者种植体周围黏膜炎和种植体周围炎的发生,并定期进行维护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To test whether or not a one- (S1) and a two-piece (S2) dental implant systems render the same biological, technical, and esthetic outcomes regarding implants and implant-supported reconstructions over an observation period of 4 to 6 years. MATERIALS AND METHODS: Sixty patients were randomly assigned to receive S1 or S2 implants. The implants were restored with either fixed or removable prostheses. The insertion of the final reconstruction was chosen as baseline. One-year and 4- to 6-year (FU-5) measurements included biological (e.g. marginal bone level, probing pocket depth, peri-implant mucositis, and peri-implantitis), technical (e.g. fracture or loosening of prosthetic screws, fracture or loosening of abutments, fracture of framework, and/or veneering ceramic (minor, major), loss of retention for cemented restorations), and esthetic parameters (visibility of the crown margin, shimmering of the implant through the mucosa, the level of the facial margo mucosae compared to the contralateral tooth or implant site and the modified papilla index) for implants and reconstructions. Survival and success rates of implants and reconstructions were calculated. Because of the asymmetric data distributions, nonparametric statistical methods were applied. RESULTS: The implant-based analysis revealed a cumulative implant survival rate of 97.9% (S1: 96.6%; S2: 98.9%) at FU-5. The median marginal bone level for group S1 changed from 0.51 mm at baseline to 0.49 mm at FU-5 and for group S2 from 1.02 mm to 1.35 mm (P < 0.001). Patient-level analyses demonstrated a frequency of peri-implant mucositis of 7.7% (S1) and 10.0% (S2) and for peri-implantitis of 7.7% (S1) and 13.3% (S2) at FU-5. The patient-based cumulative implant survival rate was 94.6% (S1: 92.3%; S2: 96.7%). The overall patient-based biological complication rate amounted to 15.4% (S1) and to 23.3% (S2) (P = 0.517), whereas the overall technical complication rates were 30.8% (S1) and 13.3% (S2) (P = 0.349). The prosthetic survival rates were 93.1% for S1 and 100% for S2 (P > 0.05). CONCLUSIONS: Both implant systems reveal high survival rates on the implant and prosthetic level. Apart from marginal bone-level changes, biological and technical outcomes did not reveal significant differences between the two implant systems.
引用
- Gamper FB, Benic GI, Sanz-Martin I, et al. Randomized controlled clinical trial comparing one-piece and two-piece dental implants supporting fixed and removable dental prostheses: 4- to 6-year observations. Clin Oral Implants Res. 2017. PMID: 28556432. doi:10.1111/clr.13025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。